• Donald E Wesson, Vandana Mathur, Navdeep Tangri, Sarah Hamlett, David A Bushinsky, and L Ebony Boulware.
• Dell Medical School - The University of Texas at Austin; Donald E Wesson Consulting, LLC, Dallas, Texas. Electronic address: dewconsulting@dewconsultingllc.onmicrosoft.com.
• Am. J. Med. 2022 Sep 1; 135 (9): 105110581051-1058.

AbstractIncreasing adverse outcomes in patients with chronic kidney disease reflect growth of patients with early-stage chronic kidney disease and their increasing per population rates of these outcomes. Progression of chronic kidney disease, more than current level of kidney function, is the primary driver of adverse chronic kidney disease-related outcomes. Racial/ethnic minorities progress faster to end-stage kidney disease with greater risk for adverse outcomes. Diabetes and hypertension cause two-thirds of end-stage kidney disease, for which primary medical care integrated with healthy eating and increased physical activity (healthy moving) slows chronic kidney disease progression. Patients with early-stage chronic kidney disease are appropriately managed by primary care practices but most lack infrastructure to facilitate this integration that reduces adverse chronic kidney disease-related outcomes. Individuals of low socioeconomic status are at greater chronic kidney disease risk, and flexible regulatory options in Medicaid can fund infrastructure to facilitate healthy eating and healthy moving integration with primary medical care. This integration promises to reduce chronic kidney disease-related adverse outcomes, disproportionately in racial/ethnic minorities, and thereby reduce chronic kidney disease-related health disparities.Copyright © 2022 Elsevier Inc. All rights reserved.

19 keywords...

hide…